Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AAAMH47902
Magnesium Glycinate Bisglycinate Haute dose 1422 mg + Vitamine B6 180 gélules Origine Angleterre (UK)
longtail
3P
MEDICAMENTS
Last 4 weeks demand
14
▼ 12.5% vs prev 4w
Offer Stock
11
Σ Stock across 3 live offers (1P + 3P) · 2026-08-05
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-08-05 snapshot
Unit price
MAD 280
avg of last 30 sells · latest 2026-08-01
AAAMH47902
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-08-03 · Total forecast: 157 units.
Actual
Realistic forecast
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnesium Glycinate Bisglycinate Haute dose 1422 mg + Vitamine B6 180 gélules Origine Angleterre (UK) · in the longtail cohort · last 4 weeks 14 units, trending down -12.5% · on-hand 11 units
Signals the model saw
- Cohort: longtail (630 days of history, 143 units sold over 52 weeks)
- Volatility (CV): 1.00 — moderate
- Recent trend: last 4w = 14 units · prev 4w = 16 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 6.8 units |
| Realistic forecast — next 4 weeks | 24.8 units |
| Realistic forecast — next 3 months | 82.0 units |
| Optimistic — next week | 11.3 units |
| Optimistic — next 4 weeks (reorder target) | 43.8 units |
| Optimistic — next 3 months (quarterly PO target) | 156.9 units |
| Legacy μ/wk (reorder pipeline) | 4.0 |
| Revenue exposure — optimistic, 3 months | MAD 43.9K |